Cancer in Indonesia has become a critical public health issue, with nearly 400,000 new cases recorded in 2020. Experts warn that this number is expected to grow significantly by 2040, driven by an aging population and continued population growth. The increasing burden highlights the urgent need for improved cancer control strategies and a shift in how the disease is managed across the country.
Current treatment options are being evaluated through genomic profiling, which aims to tailor therapies to individual patient profiles. This approach could improve outcomes and reduce the strain on healthcare resources. However, access to advanced treatments remains limited in many regions, raising concerns about the effectiveness of current healthcare infrastructure.
The government and health organizations are calling for greater investment in cancer research and treatment facilities. Strengthening the health system is seen as essential to addressing the rising incidence of cancer and ensuring better patient care. Efforts are also focusing on early detection and public awareness campaigns to combat the disease more effectively.
